Substance Use Disorder Awareness and Education

Tools and resources used to provide information and education for the purpose of increasing awareness.

Ensuring appropriate quality, access, and utilization of digital therapeutics

This worksheet provides recommendations for patients, clinicians, and payors, on how to ensure digital therapeutic quality, access, and utilization when considering mental health apps, including those for substance use.

Evaluation of Mental Health Mobile Applications

This Technical Brief proposes a framework to assess mental health mobile applications, including those related to substance use, with the aim to facilitate selection of apps. The results of applying the framework will yield summary statements on the strengths and limitations of the apps and are intended for use by providers and patients/caregivers.

What is a DTx?

This page provides an overview on Digital therapeutics, which deliver patients evidence-based therapeutic interventions that are driven by high quality software programs to treat, manage, or prevent a disease or disorder.

Fostering Resilience and Recovery: A Change Package

This Change Package provides information, action steps and tools to guide implementation of a trauma-informed primary care approach.

Advisory: Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns

This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. It also focuses on the risks and harms of CBD and clarifies common misconceptions about CBD.

Substance Use (VA)

This web page provides information for patients about substance use treatment options available through the U.S. Department of Veterans Affairs (VA) medical centers, including cognitive behavioral therapy, motivational interviewing, motivational enhancement therapy, and medications.

Fentanyl Drug Checking and Screening: Roundtable on Community Perspectives Summary Report

These proceedings summarize the discussion from the harm reduction community roundtable and supplemental individual interviews, inclusive of representatives from national and local harm reduction organizations, state and local government agencies, tribal organizations, and researchers who have experience distributing fentanyl test strips (FTS) or are knowledgeable about FTS specifically or drug checking more generally.

Sitgma and OUD

Nurse Practitioner Vanessa Loukas, a PCSS expert, discusses the issue of stigma in treating patients with opioid use disorder (OUD)—from the patients to the providers who treat them.

Words Matter: How Language Choice Can Reduce Stigma

This resource examines the role of language in perpetuating substance use disorder stigma, followed by tips for assessing when and how we may be using stigmatizing language, and steps for ensuring that the language we use and messages we deliver are positive, productive, and inclusive.

Toward an Addiction-ary: Language, Stigma, Treatment, and Policy

These are presentation slides which demonstrate the impact of stigma with facts and figures. They were presented by John F. Kelly, Ph.D. at the National Association of Drug Court Professionals Conference in Anaheim, CA in June 2016.

Subscribe to Substance Use Disorder Awareness and Education